Adakveo, a drug based on the discoveries of OMRF VP of Research Rodger McEver, is relieving pain for Danielle Jamison and others with sickle cell around the world.
OMRF discovery holds potential for reversing vision loss
OMRF scientists have identified a compound that could give birth to therapies for a host of eye diseases.
Kesimpta Medication for Multiple Sclerosis Interview With Dr. Gabriel Pardo
Dr. Gabriel Pardo helped develop the new multiple sclerosis medication Kesimpta and spoke about the drug.
OMRF receives $3.5 million to study blood clotting, vessel development
The pair of four-year, $1.75 million NIH Research Project Grants, or R01s, will support separate projects.
OMRF finds clues to reversing heart dysfunction in older adults
The risk of heart failure increases as we age. OMRF is investigating why — and whether it can be stopped.
OMRF scientists discover potential target for lymphedema therapy
A recent discovery by scientists at OMRF could aid in the development of potential therapies for lymphedema.